Categories: AnalystsCleantech

M Partners John Safrance: Not much upside in Innergex Renewable for 2012

Gilles Lefrançois, founder and Executive Chairman of Innergex Renewable. M Partners Clean Technology & Infrastructure analyst John Safrance says there are few catalysts that make Innergex an attractive play in 2012.
Longueuil, Quebec’s Innergex Renewable Energy (TSX:INE), which was founded back in 1990 but IPO’d in 2007, already knows better than most that the market can be fickle.

After debuting at $11 a share, the cleantech offering almost immediately rose to $14. But the seemingly inevitable losses that saddle many with expansionary ambitions in the space happened smack in the middle of the worst recession of a generation, and investors had little patience for the than $48 million, or $.94 cents a share the company lost in in 2008. Share of Innergex plummeted to less than three dollars.

___

This story is brought to you by Cantech Letter sponsor BIOX (TSX:BX). The largest producer of biodiesel in Canada, BIOX’s proprietary production process has the capability to use a variety of feedstock, including recycled vegetable oils, agricultural seed oils, yellow greases and tallow. For more information CLICK HERE.

___

After 2009, however, the company began to hit its stride, beginning an ramp up in operations to today’s level of twenty run-of-river power plants and five wind farms, for a total net installed capacity of 461 megawatss; enough energy to power a small city. Innergex’s fiscal 2009 revenue of $58.6 million was a quantum leap over 2008’s $7.2 million, and the company returned a solid profit of $28.5 million, or $.61 cents a share.

Innergex’s stock responded to the snapback in its business fortunes, climbing to over the $10 mark, where it has remained since mid-way through 2010. So is there another level for Innergex to be had in 2012? Probably not, says M Partners Clean Technology & Infrastructure analyst John Safrance.

In a recent research update Safrance says “Innergex’s power producing and development pipeline assets (and associated Power of Purchase Agreements) are solid but the stock looks priced for perfection.” While, argues Safrance, Innergex deserves a premium from the market, he believes it is already baked into the current share price. Most investors, he says, will probably hold the stock for its healthy 5.7% dividend yield.

With seemingly no catalysts on the horizon, Safrance has a HOLD on Innergex Renewable, with a twelve month target price of $9.45.

At press time, shares of Innergex Renewable were down 0.6% to $10.18.

___

____

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ine
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

4 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

11 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

11 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

12 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago